Mavyret is a fixed dose combination of the direct-acting antiviral agents, glecaprevir, a HCV NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor.

The Chicago hospitals will serve as "Elite Special Pathogen Treatment Centers" with the $1.5 million from IDPH.

As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...

As winter settles over Australia, it’s not just the drop in temperature we notice – there’s also a sharp rise in respiratory ...

The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by rising vaccine uptake, impr ...

RSV is responsible for around 1 lakh deaths, over 3.6 million hospitalisations in children under age of 5 every year, ...

There’s a new virus wiping out Minnesota turkey flocks, and unlike with bird flu the federal government doesn’t cover producers for losses. Last year, Minnesota growers lost an estimated 2.2 ...

Infections of the viral disease human metapneumovirus (HMPV) are rising among children northern China, according to Chinese state media. The surge in respiratory virus cases has raised alarm ...

cDirectorate of Infection, Guy's & St Thomas' NHS Foundation Trust, London, UK dDepartment of Paediatric Infectious Diseases, Alder Hey Children's NHS Foundation Trust, Liverpool, UK eRespiratory Unit ...

aNational Institute for Health and Care Research Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, UK bFaculty of Medicine ...